The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 132, No suppl_1, 7S-11S.
© 2001 American Dental Association

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SILVERMAN, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SILVERMAN, S., JR

ARTICLES

JADA Continuing Education

Demographics and occurrence of oral and pharyngeal cancers

The outcomes, the trends, the challenge



SOL SILVERMAN JR, M.A., D.D.S.


   ABSTRACT
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
Overview. This article summarizes current trends in the occurrence of, mortality rates associated with and rates of survival of oral and pharyngeal cancer.

Methods. The author reviewed relevant data and literature on these aspects of oral and pharyngeal cancer, including data from the National Cancer Institute’s Surveillance, Epidemiology and End Results program collected from 1973 to 1998.

Results. The occurrence of oral and pharyngeal cancer in the United States remains constant, at about 30,000 new cases diagnosed each year. There has been no marked improvement in the five-year survival rates, which remain at about 50 percent, despite advances in surgery and radiation. Detection of early, localized lesions has not improved significantly during the past three decades. There is a minor trend toward a younger age at diagnosis and a slight increase among women.

Conclusions. On the basis of epidemiologic data, it appears that the most important approach to decreasing morbidity and mortality associated with oral cancer is increasing early detection of localized lesions combined with appropriate treatment. Concomitantly, aggressive counseling is vital to prevent use and encourage cessation of tobacco and alcohol use.

Clinical Implications. Professional and public education about oral and pharyngeal cancer needs to be improved, and clinicians must emphasize the need for and perform routine oral cancer examinations to promote early diagnosis and treatment.

Cancer of the oral cavity and pharynx usually are surface malignancies whose signs and symptoms can be recognized early. Cancers of the oral cavity are malignancies arising in the lip, tongue, floor of the mouth, gingivae, palate, buccal mucosa/vestibule and salivary glands. Pharyngeal cancers describe those developing in the tonsillar fossa, oropharynx, nasopharynx and hypopharynx. Nearly 90 percent of these cancers are carcinomas, which occur in the stratified squamous epithelium lining these anatomical areas.1 Carcinomas are tumors that develop from uncontrolled growth of single cells or clones of cells.

The most important approach to decreasing morbidity and mortality associated with oral cancer is increasing early detection of localized lesions combined with appropriate treatment.

This article provides a brief review of current data and literature regarding the status and incidence trends of, mortality associated with and rates of survival of oral and pharyngeal cancers.


   OCCURRENCE AND SURVIVAL RATES
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
Oral and pharyngeal cancers represent approximately 3 percent of all cancers in the United States.1,2 In 2001, it is estimated that these cancers will account for 30,100 new cases and 7,800 deaths.2 The five-year relative survival rate is low: 58 percent for whites and 34 percent for African-Americans. It has remained relatively unchanged for the past three decades, despite advances in appropriate treatment3,4 (Table 1Go). In addition, for those who survive, there is a large risk of developing a new primary head or neck cancer.1 This risk appears to vary between 10 and 30 percent, and it is greater among smokers. Furthermore, and very importantly, increased morbidity resulting from aggressive treatment affects the quality of life of most of those who survive.


View this table:
[in this window]
[in a new window]
 
TABLE 1 ORAL AND PHARYNGEAL CANCER, UNITED STATES, 1992–1997: STAGE AT DIAGNOSIS AND RELATIVE FIVE-YEAR SURVIVAL RATES, BY RACE.*

 
When one sorts out the reasons for these very poor outcomes, it becomes apparent that the ineffectiveness of many treatments and the high mortality rates for oral cancer are attributable to the fact that most oral cancers are advanced lesions by the time they are diagnosed. Also, the aggressive treatment required to improve cure rates for advanced lesions is associated with increased morbidity.
The challenge for us in the dental profession is to ensure that all adult patients have a regular and comprehensive oral cancer examination.

The disappointing and frustrating aspect is that while oral cancers can be detected at early stages by a visual and tactile examination that takes only about 90 seconds, too few practitioners are conducting these examinations. Unfortunately, the diagnosis of oral cancer at an early stage has not improved over the past three decades, which may reflect the lack of effective professional and public education (Tables 2Go and 3Go). Early diagnosis by definition—diagnosis at cancer stages I and II—refers to cases in which the oral tumor does not exceed four centimeters in its largest diameter and has not spread to adjacent structures or tissues, and in which there has been no metastasis to regional cervical lymph nodes or to other organs. Early detection of oral cancers should reduce morbidity and decrease mortality. As shown in Table 1Go, those diagnosed with oral cancers in a localized stage have a higher five-year survival rate than do those diagnosed at later stages.


View this table:
[in this window]
[in a new window]
 
TABLE 2 ORAL CANCER, UNITED STATES, 1973–1996: STATUS COMPARING 11-YEAR INTERVALS FOR SITES AND STAGE AT DIAGNOSIS.*

 

View this table:
[in this window]
[in a new window]
 
TABLE 3 FIVE-YEAR RELATIVE SURVIVAL RATES* FOR THE THREE LEADING ORAL CANCER SITES, UNITED STATES, 1973–1996, COMPARING STUDY INTERVALS BY SEX AND RACE.{dagger}

 

   ETIOLOGY
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
The boxGo, "Risk Factors for Oral and Pharyngeal Cancers" (page 10S), outlines the primary risk factors for oral and pharyngeal cancers. Foremost among them are the use of tobacco products and excessive alcohol consumption, which are estimated to account for 75 percent of these cancers in the United States.57 Other potential risk factors are exposure to certain viruses (such as human papillomavirus810) and use of marijuana.11 Nutritional factors, particularly the consumption of fresh fruits and vegetables, appear to be associated with decreased risk of developing these cancers.1214


View this table:
[in this window]
[in a new window]
 
RISK FACTORS FOR ORAL AND PHARYNGEAL CANCERS.

 
Age also is a risk factor; 90 percent of oral cancers occur in people older than the age of 45 years. The mean age of onset is approximately the seventh decade of life. This makes sense, since cellular biological alterations due to long-term exposure to environmental pollutants, habits such as smoking and alcohol consumption, viruses, poor nutrition and chemicals in foods all would appear to affect the homeostatic stability of gene products that control epithelial cell proliferation and death. New trends, however, inevitably emerge; recently, there has been an increase in the number of adults in their 20s and 30s who have developed oral cancer, especially cancer of the tongue, without any apparent risk factors such as tobacco use or immunosuppression.1517


   INCIDENCE BY SEX AND SITE
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
The most recent incidence rates for cancers of the oral cavity and pharynx are from the National Cancer Institute’s Surveillance, Epidemiology, and Ends Results, or SEER, program for the 1994–1998 interval.4 Incidence rates represent the number of new cases of oral and pharyngeal cancers in a specified population during a year, which are expressed as the number of cases per 100,000 people. Incidence in men was 2.6 times that of women (14.8 compared with 5.8), and blacks had a higher rate than whites (12.4 compared with 9.7). The highest rate reported was among black men, with 20.5 cases per 100,000 people. Among women, rates for blacks and whites were alike (6.1 compared with 5.8).3

Although oral cancer occurrence in men is more frequent than in women, the sex gap is narrowing slowly. Excluding the pharynx, the male:female ratio for oral cancer is 1.8:1. This finding is explained partly by the increased and more prolonged use of tobacco products by women. Additionally, lip cancer, which occurs predominantly in white men, has been decreasing in incidence in the United States for decades.

The tongue remains the most common site of oral cancer, with 2.5 cases per 100,000 people for the 1994–1998 period. A comparison of national data between 1973 and 1984 with those from the period between 1985 and 1996 reveals that the prevalence of tongue cancer has increased from 26 percent to 30 percent of all oral cancers.17 The tongue is followed by the lip (17 percent) and the floor of the mouth (14 percent).

Data for oral cavity and pharyngeal cancer mortality rates come from the SEER program.4 The mortality rate is the number of deaths with cancer given as the underlying cause of death in a specified population during a year, expressed as the number of deaths per 100,000 people. The overall age-adjusted U.S. mortality rate for oral and pharyngeal cancers for the 1994–1998 period was 2.6. Mortality in men (3.9) was more than twice that of women (1.4). Blacks had nearly twice the mortality of whites (4.4 vs. 2.4).

The location of oral and pharyngeal cancers affects the five-year survival rates. For example, survival rates for carcinomas of the base of the tongue (distal to the circumvallate papillae) are very low compared with those for carcinomas on the oral portion of the tongue. This finding probably is explained by an associated delay in diagnosis (poorer access for examination than with the oral portion of the tongue) and the more advanced staging at diagnosis of this cancer. The relatively low occurrence of gingival and alveolar mucosal cancers suggests that there is little or no association between denture-wearing and malignant transformation.


   RACE AND ETHNICITY AS FACTORS
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
Race and ethnicity appear to be influential factors, likely because of genetic predisposition and/or socioeconomic factors, such as access to the health care system and limited awareness of methods of prevention and early detection of oral cancer. The highest incidence and mortality rates for oral cancers are found among blacks. Among American black men, the oral cavity is the fourth most frequent site of cancer.

These differences also are reflected in state data. For example, among men of all races in California, the adjusted annual incidence rate for all cancers for the period from 1993 to 1997 shows that the oral cavity was the seventh most common cancer site (14 per 100,000); in black men, it was the fourth leading site. By race or ethnicity, the incidence rate per 100,000 Californians was as follows: blacks, 17.3; non-Hispanic whites, 15.3; Asians, 10.6; and Hispanics, 7.9.17,18 These data are similar to national incidence and mortality rates.3


   METASTASES
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
Although spread of oral cancer to regional neck lymph nodes is common and indicates an advanced tumor, metastasis to other organ systems below the clavicle is rare. In these latter instances, the lung is the most common site. Metastases from oral cancers occur primarily through the lymphatic system, while distant metastases are hematogenous. Obviously, oral cancers that have metastasized require more aggressive treatment, worsen the prognosis and increase morbidity. The ability of malignant cells to metastasize varies among patients and depends on certain cell surface molecules and extracellular matrix interactions.


   CONCLUSION
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 
In summary, the epidemiologic data for oral and pharyngeal cancers yield some startling facts:

– the poor five-year survival rate continues for patients with these cancers despite advances in treatment;
most of these cancers are diagnosed as advanced, late-stage tumors;
– there are racial and ethnic disparities in incidence, mortality and five-year survival rates;
tongue cancer has increased among people younger than 40 years of age.

The challenge for us in the dental profession is to ensure that all adult patients have a regular and comprehensive oral cancer examination, as well as to educate them about the need for such an examination and about the known risk factors for these cancers. Race, ethnicity and age cannot be altered; however, lifestyle behaviors such as use of tobacco and alcohol are amenable to change and must be addressed. The dental profession has a well-deserved reputation for preventing other oral diseases. Now it is time that we focus on the prevention and early detection of oral cancer.


   FOOTNOTES
 

Dr. Silverman is a professor of oral medicine, University of California, School of Dentistry, 1750 Wawona St., San Francisco, Calif. 94116, e-mail "ssjr{at}itsa.ucsf.edu". Address reprint requests to Dr. Silverman.


   REFERENCES
 TOP
 ABSTRACT
 OCCURRENCE AND SURVIVAL RATES
 ETIOLOGY
 INCIDENCE BY SEX AND...
 RACE AND ETHNICITY AS...
 METASTASES
 CONCLUSION
 REFERENCES
 

  1. Silverman S Jr. Oral cancer. 4th ed. Hamilton, Ontario, Canada: Decker; 1998.

  2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. Calif Cancer J Clin 2001;51:15–36.

  3. Ries LA, Eisner MP, Kosary CL, et al., eds. SEER cancer statistics review, 1973–1998. Bethesda, Md.: National Cancer Institute; 2001.

  4. National Cancer Institute. Surveillance, Epidemiology, and End Results Program public-use data, 1973–1998. Rockville, Md.: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Released April 2001, based on the August 2000 submission.

  5. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993;72:1369–75.[Medline]

  6. Boffetta P, Mashberg A, Winkelmann R, Garfinkel L. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites in the oral cavity and oropharynx. Int J Cancer 1992; 52: 530–3.[Medline]

  7. Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF Jr. Cancer of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press; 1996.

  8. Fouret P, Monceaux G, Temam S, Lacourreye L, St. Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997;123:513–6.[Abstract]

  9. Gillison ML, Koch WM, Shah KV. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 1999;11:191–9.[Medline]

  10. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125–31.[Abstract/Free Full Text]

  11. Zhang Z, Morgenstern H, Spitz M, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071–8.[Abstract/Free Full Text]

  12. Krebs-Smith SM. Progress in improving diet to reduce cancer risk. Cancer 1998;83:1425–32.[Medline]

  13. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80(15):1237–43.[Abstract/Free Full Text]

  14. Potter JD, Chavez A, Chen J, Ferro-Lussi A, Hirohata T. Food, nutrition and the prevention of cancer: a global perspective. Washington: World Cancer Research Fund/American Institute of Cancer Research;1997.

  15. Pitman KT, Johnson JT, Wagner RL, Myers EN. Cancer of the tongue in patients less than forty. Head Neck 2000;22:297–302.[Medline]

  16. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000;122:44–51.[Medline]

  17. Shiboski CH, Shiboski SC, Silverman S Jr. Trends in oral cancer rates in the United States, 1973–1996. Community Dent Oral Epidemiol 2000;28:249–56.[Medline]

  18. American Cancer Society, California Division; Public Health Institute, California Cancer Registry. California facts and figures, 1999. Oakland, Calif.: American Cancer Society, California Division; 1998.




This article has been cited by other articles:


Home page
cfpHome page
J. B. Epstein, M. Gorsky, R. J. Cabay, T. Day, and W. Gonsalves
Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians
Can Fam Physician, June 1, 2008; 54(6): 870 - 875.
[Abstract] [Full Text] [PDF]


Home page
J Dent EducHome page
R. S. Wilder, K. M. Thomas, and H. Jared
Periodontal-Systemic Disease Education in United States Dental Hygiene Programs
J Dent Educ., June 1, 2008; 72(6): 669 - 679.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
P. M. MILLER, T. A. DAY, and M. C. RAVENEL
CLINICAL IMPLICATIONS OF CONTINUED ALCOHOL CONSUMPTION AFTER DIAGNOSIS OF UPPER AERODIGESTIVE TRACT CANCER
Alcohol Alcohol., March 1, 2006; 41(2): 140 - 142.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
B. W. Neville and T. A. Day
Oral Cancer and Precancerous Lesions
CA Cancer J Clin, July 1, 2002; 52(4): 195 - 215.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SILVERMAN, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SILVERMAN, S., JR


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS